| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
20,699 |
13,066 |
$2.64M |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
30,319 |
17,586 |
$1.36M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
35,596 |
17,461 |
$875K |
| G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed |
5,057 |
2,885 |
$419K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
16,178 |
11,379 |
$386K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
3,419 |
1,536 |
$180K |
| 82075 |
|
11,100 |
9,397 |
$98K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
766 |
545 |
$44K |
| L0631 |
Lumbar-sacral orthosis, sagittal control, with rigid anterior and posterior panels, posterior extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise |
243 |
86 |
$26K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
194 |
24 |
$23K |
| 99454 |
|
821 |
412 |
$19K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
344 |
203 |
$16K |
| 99457 |
|
827 |
412 |
$15K |
| 99349 |
|
275 |
170 |
$7K |
| 62322 |
|
95 |
74 |
$7K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
36 |
23 |
$5K |
| 95923 |
|
191 |
90 |
$5K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
112 |
64 |
$4K |
| 99458 |
|
160 |
76 |
$3K |
| 99492 |
|
87 |
40 |
$3K |
| 95921 |
|
174 |
70 |
$3K |
| 99493 |
|
76 |
38 |
$2K |
| 99494 |
|
81 |
37 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
230 |
101 |
$2K |
| 99072 |
|
8,447 |
4,632 |
$1K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
147 |
126 |
$959.64 |
| 99453 |
|
154 |
72 |
$678.76 |
| 93922 |
|
188 |
88 |
$655.41 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
27 |
12 |
$614.60 |
| 93040 |
|
105 |
58 |
$370.42 |
| 95924 |
|
18 |
13 |
$102.74 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
78 |
35 |
$41.20 |
| 99401 |
|
47 |
31 |
$14.39 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
5,001 |
4,549 |
$0.01 |
| A4246 |
Betadine or phisohex solution, per pint |
127 |
118 |
$0.00 |
| A4245 |
Alcohol wipes, per box |
134 |
124 |
$0.00 |
| A4212 |
Non-coring needle or stylet with or without catheter |
44 |
43 |
$0.00 |
| A4213 |
Syringe, sterile, 20 cc or greater, each |
110 |
103 |
$0.00 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
49 |
46 |
$0.00 |